Ground- and excited-state interactions of2,7,12,17-tetraphenylporphycene with model target biomolecules for type-I photodynamic therapy

Noemí Rubio, Víctor Martínez-Junza, Jordi Estruga, José I. Borrell, Margarita Mora, M. Lluïsa Sagristá, Santi Nonell

Producció científica: Article en revista indexadaArticleAvaluat per experts

7 Cites (Scopus)

Resum

Biosubstrate-sensitizer binding is one of the factors that enhances the type-I mechanism over the type-II in the whole photodynamic process. 2,7,12,17-Tetraphenylporphycene (TPPo), a second-generation photosensitizer, is a hydrophobic compound with good photophysical properties for photodynamic therapy applications that has proved its ability for the photoinactivation of different cell lines. Nevertheless, little is known about its mechanism of action. This paper focuses on the study of the interaction/binding of TPPo with different model biomolecules that may favor the type-I mechanism in the overall photodynamic process, including nucleosides, proteins, and phospholipids. Compared with more hydrophilic photosensitizers, it is concluded that TPPo is more likely to undergo type-II (singlet oxygen) than type-I (electron transfer) photodynamic processes in biological environments.

Idioma originalAnglès
Pàgines (de-a)99-106
Nombre de pàgines8
RevistaJournal of Porphyrins and Phthalocyanines
Volum13
Número1
DOIs
Estat de la publicacióPublicada - de gen. 2009

Fingerprint

Navegar pels temes de recerca de 'Ground- and excited-state interactions of2,7,12,17-tetraphenylporphycene with model target biomolecules for type-I photodynamic therapy'. Junts formen un fingerprint únic.

Com citar-ho